Toshiki Otoda Selected Research

Blood Glucose (Blood Sugar)

12/2021

Insulin receptor cleavage induced by estrogen impairs insulin signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiki Otoda Research Topics

Disease

6	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2012
4	Insulin Resistance 12/2021 - 01/2012
3	Diabetic Nephropathies (Diabetic Nephropathy) 11/2023 - 01/2014
2	Hypoglycemia (Reactive Hypoglycemia) 02/2024 - 01/2016
2	Albuminuria 10/2023 - 12/2021
2	Inflammation (Inflammations) 10/2023 - 01/2012
2	Fibrosis (Cirrhosis) 08/2023 - 01/2012
2	Non-alcoholic Fatty Liver Disease 08/2023 - 01/2012
1	Proteinuria 10/2023
1	Coma (Comas) 01/2023
1	T-Cell Leukemia (Leukemia, T Cell) 01/2023
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2023
1	Diabetes Mellitus 12/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2021
1	Hyperglycemia 03/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2014
1	Kidney Diseases (Kidney Disease) 01/2014
1	Obesity 03/2013
1	Osteoporosis 03/2013
1	Hepatocellular Carcinoma (Hepatoma) 03/2013
1	Postmenopausal Osteoporosis 03/2013
1	Venous Thromboembolism 03/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2009
1	Pancreatitis 01/2009

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2021
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2013
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2016 - 03/2015
2	Fatty Acid-Binding ProteinsIBA 11/2023 - 12/2021
2	Heparin Cofactor IIIBA 08/2023 - 12/2021
2	Thrombin FDA Link 08/2023 - 12/2021
1	Insulin (Novolin)FDA Link 02/2024
1	Insulin SecretagoguesIBA 02/2024
1	Advanced Glycation End ProductsIBA 11/2023
1	Syntex adjuvant formulationIBA 11/2023
1	AndrogensIBA 11/2023
1	Dehydroepiandrosterone SulfateIBA 11/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2023
1	ReninIBA 10/2023
1	SodiumIBA 10/2023
1	AngiotensinsIBA 10/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2023
1	Proteinase-Activated ReceptorsIBA 08/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	CreatinineIBA 12/2021
1	AlbuminsIBA 12/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2021
1	Blood Glucose (Blood Sugar)IBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016
1	voglibose (Basen)IBA 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016
1	Liraglutide FDA Link 03/2015
1	VildagliptinIBA 03/2015
1	ATP dependent 26S protease (26S proteasome)IBA 03/2013
1	Phosphotransferases (Kinase)IBA 03/2013
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2013
1	Plasminogen Activator Inhibitor 1IBA 03/2013
1	Raloxifene Hydrochloride (Evista)FDA Link 03/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2013
1	Bortezomib (Velcade)FDA Link 03/2013
1	Triglycerides (Triacylglycerol)IBA 01/2012
1	Metformin (Glucophage)FDA LinkGeneric 01/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2012
1	AntigensIBA 01/2009
1	Pancreatic Elastase (Elastase)IBA 01/2009

Therapy/Procedure

2	Therapeutics 01/2023 - 03/2015
2	Glycemic Control 01/2016 - 03/2015
1	Aftercare (After-Treatment) 10/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Diet Therapy (Therapy, Diet) 01/2016
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2014
1	Protein-Restricted Diet (Diet, Protein Restricted) 01/2014